Bolt Biotherapeutics, Inc., based in the San Francisco Bay Area, is a publicly-traded biotechnology company developing Boltbody™ Immune-stimulating Antibody Conjugates (ISAC), a new class of immuno-oncology therapeutics that have eliminated tumors following systemic administration in preclinical studies and results in the development of immunological memory, which may lead to more durable clinical responses for patients. 

Biotechnology

Bolt Biotherapeutics

Bolt Biotherapeutics' headquarters in Redwood City, CA, United States

Willie Quinn

Michael N. Alonso

Grant Yonehiro

Wes Burwell

Wesley Burwell

Sarah Nemec

Pam Howland

Lu Xu

Kathleen Laporte

Nicole Onetto

Jakob Dupont

Brian O’Callaghan

Laura Berner

Edgar G. Engleman

The Leadership Team at Bolt Biotherapeutics is responsible for setting the strategic direction and overseeing the overall operations of the company. Comprising experts in various fields such as business development, immunology, and finance, this team collaborates to drive innovation in the development of Boltbody™ ISAC therapeutics, ensuring that the company's vision aligns with its clinical and commercial goals while fostering a culture of excellence and collaboration.

Leadership Team

The Clinical Development and Research team at Bolt Biotherapeutics is responsible for designing and executing clinical trials to evaluate the safety and efficacy of Boltbody™ Immune-stimulating Antibody Conjugates (ISAC) in treating tumors. This multidisciplinary team collaborates closely on translational medicine, toxicology, and analytical development, aiming to advance innovative therapies from preclinical studies to human applications and ultimately improve patient outcomes in immuno-oncology.

Clinical Development and Research

The Laboratory Operations and Quality Control team at Bolt Biotherapeutics is responsible for ensuring the integrity and reliability of research and development processes. This team oversees laboratory practices, implements quality control measures, and manages biosample operations to maintain compliance with industry standards, ultimately supporting the advancement of innovative immune-stimulating antibody conjugates in the quest for effective immuno-oncology therapies.

Laboratory Operations and Quality Control

The Finance and Accounting team at Bolt Biotherapeutics is responsible for managing the company's financial operations, including budgeting, forecasting, and financial reporting. They ensure compliance with regulatory standards, oversee accounts payable processes, and maintain accurate financial records, enabling the company to effectively allocate resources to support its innovative immuno-oncology research initiatives.

Bolt Biotherapeutics

Org chart

Board & advisors

Teams

Leadership Team

Clinical Development and Research

Laboratory Operations and Quality Control

Finance and Accounting

Offices

Bolt Biotherapeutics

Org chart

Board & advisors

Teams

Leadership Team

Clinical Development and Research

Laboratory Operations and Quality Control

Finance and Accounting

Offices

Related companies